Efficacy News and Research

RSS
TWi Pharmaceuticals completes AC-201 phase II study on type II diabetes

TWi Pharmaceuticals completes AC-201 phase II study on type II diabetes

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Potential new drug to treat common inherited kidney disease

Potential new drug to treat common inherited kidney disease

Novel integrase inhibitor dolutegravir shows promise for HIV-1 treatment

Novel integrase inhibitor dolutegravir shows promise for HIV-1 treatment

SAGE Labs, Autism Speaks expand partnership to create first rat models for translational research

SAGE Labs, Autism Speaks expand partnership to create first rat models for translational research

Healthpoint Biotherapeutics announces results from HP802-247 Phase 2b trial on venous leg ulcers

Healthpoint Biotherapeutics announces results from HP802-247 Phase 2b trial on venous leg ulcers

New FDA risk management plan aims to reduce opioid abuse in the U.S.

New FDA risk management plan aims to reduce opioid abuse in the U.S.

Researchers develop bioactive coating that actively suppresses brain's immune response

Researchers develop bioactive coating that actively suppresses brain's immune response

Shampoo effective for pruritus relief in dogs

Shampoo effective for pruritus relief in dogs

RBC transfusion use in neonates requires more study

RBC transfusion use in neonates requires more study

Breast cancer drug bevacizumab (Avastin): an interview with Dr Anna Dorothea Wagner

Breast cancer drug bevacizumab (Avastin): an interview with Dr Anna Dorothea Wagner

Poor sleep can reduce effectiveness of vaccines

Poor sleep can reduce effectiveness of vaccines

New drug may be useful in treating long QT syndrome

New drug may be useful in treating long QT syndrome

InSite Vision second quarter total revenues decrease to $1.8 million

InSite Vision second quarter total revenues decrease to $1.8 million

InSite Vision commences enrollment in BromSite Phase 3 clinical trial

InSite Vision commences enrollment in BromSite Phase 3 clinical trial

Population Genetics validates GenomePooling™ for cancer

Population Genetics validates GenomePooling™ for cancer

GenomePooling™ method is sensitive and accurate

GenomePooling™ method is sensitive and accurate

Brain injury patterns predict outcomes in oxygen-starved infants

Brain injury patterns predict outcomes in oxygen-starved infants

Intensive multidisciplinary approach effective for chronic back pain

Intensive multidisciplinary approach effective for chronic back pain

Treatments for peripheral neuropathic pain compared

Treatments for peripheral neuropathic pain compared

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.